These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31273175)

  • 1. [Effectiveness of Ramucirumab Therapy for Advanced Gastric Cancer after Stent Placement for Esophagogastric Junction Carcinoma Obstruction-A Case Report].
    Takeuchi T; Yuasa Y; Okitsu H; Maki H; Tsuneki T; Matsuo Y; Edagawa H; Mori O; Miyamoto N; Eto S; Fujiwara S; Tomibayashi A; Ishikura H
    Gan To Kagaku Ryoho; 2019 Jun; 46(6):1057-1059. PubMed ID: 31273175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Three Patients with Gastric Cancer Who Underwent Surgery during Ramucirumab Treatment].
    Omori H; Kawai S; Makuuchi R; Irino T; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Yasui H; Terashima M
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):1021-1023. PubMed ID: 29138380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer.
    Kimura M; Usami E; Teramachi H; Yoshimura T
    J Oncol Pharm Pract; 2018 Sep; 24(6):403-411. PubMed ID: 28436252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eleven Patients with Gastric Cancer Who Received Chemotherapy after Stent Placement for Gastric Outlet Obstruction].
    Endo S; Nakagawa T; Konishi K; Ikenaga M; Ohta K; Nakashima S; Matsumoto K; Nishikawa K; Ohmori T; Yamada T
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):71-74. PubMed ID: 28174384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wallflex duodenal stenting for gastric outlet obstruction caused by inoperable advanced gastric cancer].
    Takeno A; Tamura S; Miki H; Kawashima H; Mukai Y; Hamanaka M; Ono H; Uchiyama C; Kanemura T; Suzuki R; Nakahira S; Nakata K; Okamura S; Takeda Y; Kato T
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2134-6. PubMed ID: 22202307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
    Wilke H; Muro K; Van Cutsem E; Oh SC; Bodoky G; Shimada Y; Hironaka S; Sugimoto N; Lipatov O; Kim TY; Cunningham D; Rougier P; Komatsu Y; Ajani J; Emig M; Carlesi R; Ferry D; Chandrawansa K; Schwartz JD; Ohtsu A;
    Lancet Oncol; 2014 Oct; 15(11):1224-35. PubMed ID: 25240821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Büyükkaramikli NC; Blommestein HM; Riemsma R; Armstrong N; Clay FJ; Ross J; Worthy G; Severens J; Kleijnen J; Al MJ
    Pharmacoeconomics; 2017 Dec; 35(12):1211-1221. PubMed ID: 28656543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW.
    Muro K; Cho JY; Bodoky G; Goswami C; Chao Y; Dos Santos LV; Shimada Y; Topuzov E; Van Cutsem E; Tabernero J; Zalcberg J; Chau I; Cascinu S; Cheng R; Hsu Y; Emig M; Orlando M; Fuchs C
    J Gastroenterol Hepatol; 2018 Apr; 33(4):814-824. PubMed ID: 28960444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Administering Ramucirumab Safely after Inserting an Intestinal Stent, Due to Peritoneal Metastasis of Gastric Cancer-A Case Report].
    Orimoto N; Suda T; Takahashi K; Iwasaki K; Watanabe T; Makuuchi Y; Ota Y; Nagakawa Y; Seshimo A; Katsumata K; Tsuchida A
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):313-315. PubMed ID: 32381973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
    Di Bartolomeo M; Niger M; Morano F; Corallo S; Antista M; Tamberi S; Lonardi S; Di Donato S; Berardi R; Scartozzi M; Cardellino GG; Di Costanzo F; Rimassa L; Luporini AG; Longarini R; Zaniboni A; Bertolini A; Tomasello G; Pinotti G; Scagliotti G; Tortora G; Bonetti A; Spallanzani A; Frassineti GL; Tassinari D; Giuliani F; Cinieri S; Maiello E; Verusio C; Bracarda S; Catalano V; Basso M; Ciuffreda L; De Vita F; Parra HS; Fornaro L; Caporale M; de Braud F; Pietrantonio F
    BMC Cancer; 2019 Mar; 19(1):283. PubMed ID: 30922323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical Experience of Ramucirumab for Treating Advanced Gastric Cancer].
    Kimura Y; Makari Y; Mikami J; Kamigaki S; Ikejima A; Fujii C; Sawada G; Nakahira S; Yamamura J; Nakata K; Yamamoto T; Ikeda N; Tsujie M; Fujita J; Ohzato H
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1193-1196. PubMed ID: 27760936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Clinical Effect of Ramucirumab in the Treatment of Advanced Gastric Cancer in Our Hospital].
    Kenno S; Takahashi S; Noguchi K; Yamagami H; Ishizu H; Takahashi M
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):79-81. PubMed ID: 29362314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Inoperable Advanced Gastric Cancer with Gastric Outlet Obstruction in Which Oral Intake Could Be Prolonged by Duodenal Stenting].
    Takeno A; Tamura S; Taniguchi H; Murakami K; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Sakisaka H; Takeda Y; Kato T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1686-8. PubMed ID: 26805138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramucirumab and Paclitaxel Administered Every 2 Weeks (mRAINBOW Regimen) in Advanced Gastroesophageal Adenocarcinoma.
    Rogers JE; Xiao L; Amlashi FG; Elimova E; Blum Murphy MA; Sanders E; Shanbhag N; Thomas I; Ajani JA
    Oncology; 2019; 96(5):252-258. PubMed ID: 30893708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy].
    Kimura Y; Makari Y; Mikami J; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Fujita J; Furukawa H; Yasuda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1080-1082. PubMed ID: 29394540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
    Fuchs CS; Tomasek J; Yong CJ; Dumitru F; Passalacqua R; Goswami C; Safran H; Dos Santos LV; Aprile G; Ferry DR; Melichar B; Tehfe M; Topuzov E; Zalcberg JR; Chau I; Campbell W; Sivanandan C; Pikiel J; Koshiji M; Hsu Y; Liepa AM; Gao L; Schwartz JD; Tabernero J;
    Lancet; 2014 Jan; 383(9911):31-39. PubMed ID: 24094768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Advanced Gastric Cancer Responding to Neoadjuvant Docetaxel/CDDP/S-1 Therapy with Metallic Stent Placement, Leading to Curative Surgery].
    Yazawa K; Kunisaki C; Kimura J; Takagawa R; Minami Y; Makino H; Suzuki Y; Tsuburaya A; Akiyama H; Endo I
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2049-51. PubMed ID: 26805260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrectomy for Bleeding Gastric Cancer During Ramucirumab plus Paclitaxel Therapy-A Case Report].
    Mori K; Aoyama T; Morita J; Maezawa Y; Amano S; Sawazaki S; Numata M; Tamagawa H; Sato T; Oshima T; Yoshikawa T; Yukawa N; Masuda M; Rino Y
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):586-588. PubMed ID: 30914622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study.
    Yamaguchi K; Fujitani K; Nagashima F; Omuro Y; Machida N; Nishina T; Koue T; Tsujimoto M; Maeda K; Satoh T
    Gastric Cancer; 2018 Nov; 21(6):1041-1049. PubMed ID: 29508095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer.
    Hayase S; Yamada L; Ujiie D; Nirei A; Tada T; Hanayama H; Monma T; Saze Z; Ohki S; Kono K
    Fukushima J Med Sci; 2019; 65(1):6-12. PubMed ID: 30996218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.